The total return over the past 12 months is +121.66% vs. +16.94% for the S&P 500. So far it's up +45.30% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +121.66% | (7.70%) | (9.35%) | N/A | N/A | N/A |
| Total Return CAGR | +121.66% | (7.70%) | (9.35%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | +94.48% | +148.45% | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Orchestra BioMed Holdings, Inc. (OBIO)
| Year | Start price | End price | OBIO Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $4.15 | $6.03 | +45.30% | +14.51% | +30.79% |
| 2025 | $4.00 | $4.15 | +3.75% | +17.72% | (13.97%) |
| 2024 | $9.13 | $4.00 | (56.19%) | +24.89% | (81.08%) |
| 2023 | $9.98 | $9.13 | (8.52%) | +26.19% | (34.71%) |
| 2022 | $10.08 | $9.98 | (0.99%) | (18.17%) | +17.18% |
| 2021 | $12.81 | $10.08 | (21.31%) | +28.74% | (50.05%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
